Tivic Health Systems shares are trading higher after the company announced its funded study started enrollment for its non-invasive bioelectronic device approach to vagus nerve stimulation.
Portfolio Pulse from Benzinga Newsdesk
Tivic Health Systems has begun enrollment for its funded study on a non-invasive bioelectronic device approach to vagus nerve stimulation. This news has led to an increase in the company's share price.
August 16, 2023 | 2:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tivic Health Systems' shares are trading higher following the announcement of the start of enrollment for its funded study on a non-invasive bioelectronic device.
The announcement of the start of enrollment for Tivic Health Systems' funded study on a non-invasive bioelectronic device has been positively received by the market, leading to an increase in the company's share price. This suggests that investors are optimistic about the potential of this study and its impact on the company's future performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100